| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 09/25/2001 | US6294661 Compounds |
| 09/25/2001 | US6294660 Nucleic acids encoding B7-1 and B7-2 molecules |
| 09/25/2001 | US6294653 RNA binding protein and binding site useful for expression of recombinant molecules |
| 09/25/2001 | US6294649 A cytotoxic peptide; therapy for breast cancer, brain tumor, kidney tumors; antitumor/antiproliferative/anticarcinogenic agents |
| 09/25/2001 | US6294585 Treatment of neurodegenerative diseases |
| 09/25/2001 | US6294383 Porcine neural cells and their use in treatment of neurological deficits due to neurodegenerative diseases |
| 09/25/2001 | US6294381 Enriching for cd11c negative dendritic cells by contacting with anti-cd123 antibody, then selecting positive cells |
| 09/25/2001 | US6294380 Liver cell clones for use in extracorporeal liver-assist device |
| 09/25/2001 | US6294355 Polynucleotide encoding polypeptide of defined amino acid seuqence; diagnosis; drug screening; antiepileptic agents; treatment of nervous system disorders; treatment of drug abuse, drug dependence |
| 09/25/2001 | US6294353 Targeted hetero-association of recombinant proteins to multi-functional complexes |
| 09/25/2001 | US6294348 Detection of moduators of signal transduction; incubate sample with modulator and monitor sample for adjustment in signal transduction |
| 09/25/2001 | US6294347 Human FCγ receptor III |
| 09/25/2001 | US6294346 Preparing cell culture of neurospheres comprising cluster of neural stem cells, contacting with agent, and determining effect on proliferation, differentiation or survival; treatment of nervous system disorders |
| 09/25/2001 | US6294332 Composition and methods for modulating the length of telomeres |
| 09/25/2001 | US6294320 Cell matrix plaques of initial bone formation |
| 09/25/2001 | US6294184 Bacillus thuringiensis strains, |
| 09/25/2001 | US6294169 Interleukin-1 beta converting enzyme like apoptotic protease-6 |
| 09/25/2001 | CA2167048C Identification of ligands by selective amplification of cells transfected with receptors |
| 09/20/2001 | WO2001069244A2 Method for labeling individual cells |
| 09/20/2001 | WO2001068923A2 Mitochondrial dosimeter |
| 09/20/2001 | WO2001068907A2 Stable expression of polymorphous forms of human cytochrome p450 2d6 |
| 09/20/2001 | WO2001068895A1 High fidelity reverse transcriptases and uses thereof |
| 09/20/2001 | WO2001068888A2 Production of chimeric capsid vectors |
| 09/20/2001 | WO2001068882A2 Methods for homologous recombination |
| 09/20/2001 | WO2001068880A2 Estrogen-regulated myo-inositol phosphate synthase: compositions and methods of use |
| 09/20/2001 | WO2001068864A1 Fungal transcriptional activator useful in methods for producing polypeptides |
| 09/20/2001 | WO2001068862A1 Insulin homolog polypeptide zins4 |
| 09/20/2001 | WO2001068861A2 THREE-DIMENSIONAL MODEL OF A Fc REGION OF AN IgE ANTIBODY AND USES THEREOF |
| 09/20/2001 | WO2001068855A2 Gtp-binding protein gamma-12 subunit |
| 09/20/2001 | WO2001068854A2 Fibroblast growth factor-like molecules and uses thereof |
| 09/20/2001 | WO2001068852A2 Apolipoprotein-a-i regulation of t-cell signalling |
| 09/20/2001 | WO2001068851A2 Polypeptides and nucleic acids encoding same |
| 09/20/2001 | WO2001068848A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/20/2001 | WO2001068836A2 Methods and compositions for rna interference |
| 09/20/2001 | WO2001068833A2 Recombinant hhv8 dna |
| 09/20/2001 | WO2001068828A2 Compositions and methods for regulated protein expression in gut |
| 09/20/2001 | WO2001068827A1 A process for the production of human interferon alpha from genetically engineered yeast |
| 09/20/2001 | WO2001068824A2 Renilla reniformis fluorescent proteins, nucleic acids encoding the fluorescent proteins and the use thereof in diagnostics, high throughput screening and novelty items |
| 09/20/2001 | WO2001068820A1 Altered strain of the modified vaccinia virus ankara (mva) |
| 09/20/2001 | WO2001068819A1 Improved methods to isolate, identify, quantify, and propagate chicken infectious anemia virus and high titer vaccine |
| 09/20/2001 | WO2001068818A2 Hcv ns2/3 fragments and uses thereof |
| 09/20/2001 | WO2001068815A1 Embryonic stem cells and neural progenitor cells derived therefrom |
| 09/20/2001 | WO2001068814A2 Multipotent cell and cardiomyocyte cell populations, and routes to and uses of same |
| 09/20/2001 | WO2001068813A1 L-leucyl-l-leucine methyl ester treatment of donor lypmhocyte infusions in hematopoietic stem cell transplant patients |
| 09/20/2001 | WO2001068811A2 Method for in vitro production of three-dimensional vital cartilage or bone tissue and use thereof as transplant material |
| 09/20/2001 | WO2001068805A2 Human olfactory receptors and genes encoding same |
| 09/20/2001 | WO2001068799A1 Cell cultivation-support material, method of cocultivation of cells and cocultivated cell sheet obtained therefrom |
| 09/20/2001 | WO2001068710A1 Monoclonal antibodies to the human ldl receptor, their production and use |
| 09/20/2001 | WO2001068708A2 Human and humanized fap-alpha-specific antibodies |
| 09/20/2001 | WO2001068706A1 Melanin concentrating hormone receptor chimeric and fusion proteins |
| 09/20/2001 | WO2001068705A2 Il-17 receptor like molecules and uses thereof |
| 09/20/2001 | WO2001068704A2 G-protein coupled receptors |
| 09/20/2001 | WO2001068696A1 Human immune response proteins |
| 09/20/2001 | WO2001068695A2 Factor-h related protein 5 (fhr-5) and antibodies thereto |
| 09/20/2001 | WO2001068677A2 Derivatives of breast canacer antigen her-2 for therapeutical use |
| 09/20/2001 | WO2001068565A2 Chemoselective ligation by use of a phosphine |
| 09/20/2001 | WO2001068226A2 A method of sorting cells |
| 09/20/2001 | WO2001068158A1 Coating that promotes endothelial cell adherence |
| 09/20/2001 | WO2001068148A1 Systemic gene delivery vehicles for the treatment of tumors |
| 09/20/2001 | WO2001068110A1 Method and apparatus for inducing a cellular response |
| 09/20/2001 | WO2001068109A1 Modified factor viii |
| 09/20/2001 | WO2001068108A1 Induction of beta cell differentiation in human cells by stimulation of the glp-1 receptor |
| 09/20/2001 | WO2001067855A2 Transgenic mice containing targeted gene disruptions |
| 09/20/2001 | WO2001049745A9 Methods and compositions for determining the purity of chemically synthesized nucleic acids |
| 09/20/2001 | WO2001042439A8 Molecular display on multimeric protein scaffolds derived from the e2 component of the alpha-ketoacid dehydrogenase |
| 09/20/2001 | WO2001030851A3 Idiotype vaccines |
| 09/20/2001 | WO2001029070A8 Modulation of t cell differentiation for the treatment of t helper cell mediated diseases |
| 09/20/2001 | WO2001019851A3 Opaminergic neuronal survival-promoting factors and uses thereof |
| 09/20/2001 | WO2001018192A3 Synthetic vectors, transgenic plants containing them, and methods for obtaining them |
| 09/20/2001 | WO2001018051A3 Mammalian interleukin-12 p40 and interleukin b30, combinations thereof, antibodies, uses in pharmaceutical compositions |
| 09/20/2001 | WO2001016317A3 Polycyclic aromatic hydrocarbon induced molecules |
| 09/20/2001 | WO2001016165A3 Apoptin-associating protein |
| 09/20/2001 | WO2001014538A3 Plants with modified polyunsaturated fatty acids |
| 09/20/2001 | WO2001014424A3 Human ctla-4 antibodies and their uses |
| 09/20/2001 | WO2001011007A3 Bioartificial device for propagation of tissue, preparation and uses thereof |
| 09/20/2001 | WO2001007065B1 PRODUCTION OF rhPBGD AND NEW THERAPEUTIC METHODS FOR TREATING PATIENTS WITH ACUTE INTERMITTENT PORPHYRIA (AIP) AND OTHER PORPHYRIC DISEASES |
| 09/20/2001 | WO2001002540A9 Adenoviral vectors for treating disease |
| 09/20/2001 | WO2000075335A3 Bacteriophage rm 378 of a thermophilic host organism |
| 09/20/2001 | WO2000044774A9 Inhibition of stat3 signal transduction for human cancer therapy |
| 09/20/2001 | WO2000037491A3 Dnas encoding proteins with signal sequences |
| 09/20/2001 | WO2000037490A3 Outer surface proteins, their genes, and their use |
| 09/20/2001 | WO1999040102A9 Novel molecules of the card-related protein family and uses thereof |
| 09/20/2001 | US20010023500 Leukotriene B4 receptor transgenic mice |
| 09/20/2001 | US20010023073 Co-cultivation of cells in a micropatterned configuration |
| 09/20/2001 | US20010023072 Enrichment of dendritic cells form blood |
| 09/20/2001 | US20010023062 Screening receptors |
| 09/20/2001 | US20010023061 Assaying the effect of test tumor cell modulation |
| 09/20/2001 | US20010022977 Administering apoptosis agent |
| 09/20/2001 | EP1144608A3 Synthetic vectors, transgenic plants containing them, and methods for obtaining them |
| 09/20/2001 | DE10013618A1 New polypeptides from Drosophila melanogaster have biological activity of peptide receptor, useful to find new compounds for plant protection and insecticides |
| 09/20/2001 | DE10013580A1 Rezeptor für Latrotoxin aus Insekten Receptor for Latrotoxin from insects |
| 09/20/2001 | DE10012220A1 Test system comprising cells expressing different cytochrome P450 2D6 alleles used to investigate genetically caused metabolite toxicity and to determine toxic, mutagenic or carcinogenic effect of compounds |
| 09/20/2001 | DE10011998A1 A new growth promoting active substance combination contains L-serine, L-asparagine and/or L-glutamine provides a growth medium for cells, particularly human or mammalian cells |
| 09/20/2001 | DE10010950A1 Disposable bioreactor for cultivation of dendritic cells used in immuno therapy, comprises a substrate-carrying organic material located in a pouch |
| 09/20/2001 | DE10009030A1 Hybrid cell, useful as therapeutic vaccine against cancer and viral, bacterial and protozoal infections, comprises allogeneic dendritic cells fused to autologous non-dendritic cells |
| 09/20/2001 | DE10005329A1 Stimulating growth of hair, e.g. on the head, eyebrows or eyelashes, by subcutaneous application of a preparation containing stem cells and/or preformed hair cells |
| 09/20/2001 | CA2674427A1 A method of sorting cells |
| 09/20/2001 | CA2403405A1 Hcv ns2/3 fragments and uses thereof |
| 09/20/2001 | CA2403397A1 Methods and compositions for rna interference |
| 09/20/2001 | CA2403222A1 Mitochondrial dosimeter |